CA
NZ
UK
AU
IND
US
…
Janel Corporation, through its subsidiaries, provides logistics services worldwide. It operates through three segments: Logistics, Life Sciences, and Manufacturing. The Logistics segment provides cargo transportation logistics management services, including freight forwarding by air, ocean, and land-based carriers; customs brokerage services; warehousing and distribution services; and other value added logistic services, as well as customs entry filing, cargo insurance procurement, logistics planning, product repackaging, and online shipment tracking services. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immuno-reagents for biomedical research; provides antibody manufacturing for academic and industry research scientists; and produces products for other life science companies on an original equipment manufacturer basis. The Manufacturing segment manufactures and distributes mixing equipment and apparatus for various industries, such as chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. The company was formerly known as Janel World Trade Ltd. and changed its name to Janel Corporation in April 2015. Janel Corporation was founded in 1974 and is headquartered in New York, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Janel Corp is an OTCQX-listed company for which public disclosures about core operations and financial performance are limited, making its business activities difficult to verify. Long-term growth drivers are not clearly described in available filings or public commentary, so potential upside may depend on improved operational disclosure, strategic restructuring, or asset developments should management provide more detail. Investors may find speculative interest in any future transparency or corporate actions but should view the company as opaque until material information is published.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Income before tax | 0.53M | 0.05M | 6.16M | -2.23M | 0.38M |
| Minority interest | 0.00M | -0.40M | - | 0.60M | 0.62M |
| Net income | 0.72M | -2.14M | 5.20M | -1.73M | 0.20M |
| Selling general administrative | 50.98M | 54.72M | 27.36M | 24.29M | 22.61M |
| Gross profit | 55.67M | 66.20M | 32.43M | 23.52M | 20.31M |
| Reconciled depreciation | 2.61M | 2.46M | 1.49M | 1.23M | 1.20M |
| Ebit | 2.46M | 9.50M | 3.95M | -1.72M | 0.88M |
| Ebitda | 5.07M | 12.37M | 5.35M | -0.48M | 1.78M |
| Depreciation and amortization | 2.61M | 2.87M | 1.40M | 1.24M | 0.91M |
| Operating income | 2.60M | 9.50M | 3.95M | -1.72M | 0.89M |
| Other operating expenses | 183.85M | 307.37M | 142.47M | 84.15M | 66.63M |
| Interest expense | 2.00M | 1.28M | 0.59M | 0.52M | 0.50M |
| Tax provision | -0.20M | 2.19M | 0.96M | -0.51M | 0.33M |
| Net interest income | -2.00M | -1.28M | -0.59M | -0.52M | -0.69M |
| Income tax expense | -0.20M | 2.19M | 0.96M | -0.51M | 0.13M |
| Total revenue | 186.45M | 316.86M | 146.42M | 82.43M | 67.52M |
| Total operating expenses | 53.07M | 56.70M | 28.48M | 25.25M | 19.43M |
| Cost of revenue | 130.78M | 250.67M | 113.99M | 58.91M | 47.21M |
| Total other income expense net | -0.08M | -9.45M | 2.21M | -0.51M | -0.01M |
| Net income from continuing ops | 0.72M | -2.14M | 5.20M | -1.73M | 0.62M |
| Net income applicable to common shares | - | -3.13M | 4.44M | -2.40M | -0.30M |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Total assets | 96.83M | 126.53M | 115.92M | 63.03M | 50.91M |
| Intangible assets | 22.20M | 22.42M | 24.17M | 13.33M | 12.35M |
| Other current assets | 4.46M | 3.42M | 3.00M | 0.43M | 0.35M |
| Total liab | 77.86M | 108.20M | 97.81M | 50.35M | 35.88M |
| Total stockholder equity | 18.97M | 18.33M | 18.12M | 12.68M | 15.03M |
| Other current liab | 0.59M | 8.25M | 1.05M | 4.85M | 2.22M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | 2.10M | 1.38M | 3.52M | -1.68M | -0.61M |
| Other liab | - | 5.84M | 5.44M | 2.33M | 2.33M |
| Good will | 20.32M | 18.62M | 18.49M | 14.15M | 11.46M |
| Other assets | - | 0.52M | 0.58M | 0.27M | 0.09M |
| Cash | 2.46M | 6.59M | 6.23M | 3.35M | 0.58M |
| Total current liabilities | 58.84M | 85.04M | 79.56M | 38.06M | 29.64M |
| Current deferred revenue | 8.37M | 2.54M | 8.93M | - | - |
| Net debt | 36.87M | 39.60M | 38.12M | 18.46M | 14.22M |
| Short term debt | 24.43M | 29.29M | 32.34M | 12.45M | 10.63M |
| Short long term debt | 22.41M | 27.46M | 31.05M | 11.73M | 9.37M |
| Short long term debt total | 39.33M | 46.19M | 44.36M | 21.80M | 14.80M |
| Other stockholder equity | 16.87M | 16.94M | 14.60M | 14.36M | 15.63M |
| Property plant equipment | - | 10.70M | 7.91M | 7.60M | 3.95M |
| Total current assets | 39.29M | 71.89M | 64.78M | 27.69M | 23.06M |
| Long term investments | 1.57M | 2.37M | - | - | - |
| Net tangible assets | - | -22.71M | -24.54M | -14.80M | -12.24M |
| Net receivables | 27.52M | 57.08M | 52.31M | 20.25M | 19.73M |
| Long term debt | 9.21M | 12.90M | 10.27M | 7.43M | 7.14M |
| Inventory | 4.85M | 4.80M | 3.23M | 3.67M | 2.39M |
| Accounts payable | 25.45M | 44.96M | 37.24M | 20.77M | 16.80M |
| Accumulated other comprehensive income | - | - | - | -2.00M | - |
| Non currrent assets other | -0.27M | -2.02M | 0.58M | 0.27M | 0.26M |
| Non current assets total | 57.55M | 54.64M | 51.15M | 35.34M | 27.86M |
| Capital lease obligations | 7.71M | 5.83M | 3.03M | 2.64M | - |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Investments | -6.50M | -9.97M | -16.11M | -1.54M | -6.60M |
| Change to liabilities | - | 8.55M | 16.29M | -3.19M | 4.70M |
| Total cashflows from investing activities | - | -11.47M | -16.11M | -1.54M | -6.60M |
| Net borrowings | - | -1.15M | 18.24M | 2.64M | 1.25M |
| Total cash from financing activities | -9.02M | -0.28M | 19.19M | 3.28M | 6.35M |
| Change to operating activities | - | -0.33M | -1.36M | 0.14M | -0.02M |
| Net income | 0.72M | -2.14M | 5.20M | -1.73M | 0.25M |
| Change in cash | -4.13M | 0.36M | 2.88M | 1.19M | -0.40M |
| Begin period cash flow | 6.59M | 6.23M | 3.35M | 2.16M | 0.99M |
| End period cash flow | 2.46M | 6.59M | 6.23M | 3.35M | 0.58M |
| Total cash from operating activities | 11.39M | 12.11M | -0.20M | -0.55M | 0.85M |
| Issuance of capital stock | 0.00M | 4.00M | 0.60M | 0.33M | 0.00M |
| Depreciation | 2.61M | 2.46M | 1.49M | 1.23M | 0.91M |
| Dividends paid | 0.80M | 0.66M | 0.77M | 0.06M | 1.09M |
| Change to inventory | 0.03M | -1.50M | -0.04M | -0.17M | -0.07M |
| Change to account receivables | 29.80M | -5.87M | -20.70M | 2.49M | -3.94M |
| Sale purchase of stock | 0.00M | -2.34M | 0.17M | -0.45M | -0.40M |
| Other cashflows from financing activities | -5.89M | -0.83M | 22.14M | 0.55M | 6.60M |
| Change to netincome | - | 11.34M | -1.09M | 0.65M | 1.48M |
| Capital expenditures | 0.36M | 0.55M | 0.23M | 1.30M | 0.09M |
| Change in working capital | 8.54M | 0.84M | -5.81M | -0.72M | -1.29M |
| Stock based compensation | 0.23M | 0.83M | 0.12M | 0.27M | 0.68M |
| Other non cash items | 8.73M | 9.87M | -1.93M | 1.00M | 0.23M |
| Free cash flow | 11.03M | 11.56M | -0.43M | -1.85M | 0.76M |
Sector: Industrials Industry: Integrated Freight & Logistics
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| JANL Janel Corp |
- -% |
43.00 | 69.44 | - | 0.18 | 1.75 | 0.38 | 13.68 |
| FDX FedEx Corporation |
0.64 0.20% |
319.48 | 21.06 | 17.86 | 1.02 | 3.16 | 1.39 | 11.61 |
| UPS United Parcel Service Inc |
0.09 0.08% |
111.05 | 19.06 | 12.89 | 0.97 | 5.79 | 1.24 | 10.27 |
| DHLGY Deutsche Post AG |
-0.14 0.42% |
32.95 | 16.10 | 15.72 | 0.78 | 2.52 | 0.95 | 7.03 |
| DSDVY DSV Panalpina A/S ADR |
-1.62 1.49% |
107.32 | 48.35 | 24.63 | 0.26 | 3.46 | 1.99 | 20.03 |
Janel Corporation, through its subsidiaries, provides logistics services worldwide. It operates through three segments: Logistics, Life Sciences, and Manufacturing. The Logistics segment provides cargo transportation logistics management services, including freight forwarding by air, ocean, and land-based carriers; customs brokerage services; warehousing and distribution services; and other value added logistic services, as well as customs entry filing, cargo insurance procurement, logistics planning, product repackaging, and online shipment tracking services. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immuno-reagents for biomedical research; provides antibody manufacturing for academic and industry research scientists; and produces products for other life science companies on an original equipment manufacturer basis. The Manufacturing segment manufactures and distributes mixing equipment and apparatus for various industries, such as chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. The company was formerly known as Janel World Trade Ltd. and changed its name to Janel Corporation in April 2015. Janel Corporation was founded in 1974 and is headquartered in New York, New York.
| Name | Title | Year Born |
|---|---|---|
| Ms. Dominique Schulte | Chairman, CEO & Pres | 1973 |
| Mr. Vincent A. Verde | Principal Financial Officer, Treasurer & Sec. | 1963 |
| Mr. Brendan J. Killackey | Chief Information Officer & Exec. Director | 1974 |
| Mr. John Joseph Gonzalez II | Sr. Advisor for Mergers & Acquisitions and Independent Director | 1950 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.26%
Communication Services
-0.18%
Consumer Cyclical
-0.36%
Consumer Defensive
+0.07%
Energy
-0.01%
Financial Services
-0.26%
Financials
-2.20%
Healthcare
-0.55%
Industrials
-0.08%
Real Estate
-0.33%
Technology
-0.70%
Utilities
-0.41%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...